I believe Cytodyn is keeping arms length distance from Amarex until the actual report is produced. Information seen before that would most likely require a PR since it would be material whether the news was good or bad. Amarex can send the unblinded data before that to the FDA for their review along with sending it to other countries who want to review it. But in order to get a complete picture, the report is required. . This is what I mentioned back in early January I felt there would be no information until at least mid February..